Manjiree Karandikar, MD
Associate Professor
Pediatrics
School of Medicine
My clinical interests lie in the diagnosis, treatment, and prevention of infections in immunocompromised hosts (ICH). I am a member of the Pediatric ID ICH team. In addition, I am committed to advancing medical education across the spectrum of training.
Show full bio (60 words) Hide full bio
I serve as the Co-Director for the Pathogen and Host Defense block in the School of Medicine, and am the Program Director for the Pediatric Infectious Disease Fellowship Program. I am a member of the UCSF Haile T. Debas Academy of Medical Educators. I am past-chair or the PIDS Transplant ID Education Sub-committee.
Awards
Show all (2) Hide
- Haile T. Debas Academy of Medical Educators, UCSF School of Medicine, 2025
- Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, UCSF School of Medicine, 2021
Education & Training
Show all (6) Hide
- Diversity, Equity, and Inclusion Champion Training University of California 12/2020
- Fellowship Pediatric Infectious Disease Boston Children's Hospital 06/2018
- Certificate Advanced Training in Clinical and Translational Research Clinical / Translational Research Academy, Harvard Catalyst 05/2018
- Residency Pediatrics Harbor UCLA Medical Center 06/2015
- MD Medicine Wayne State University School of Medicine 05/2012
- MBS Biopharmaceutical Drug Discovery and Development Keck Graduate Institute 05/2007
Interests
Show all (3) Hide
- immunocompromised populations
- quality improvement
- pediatric infectious disease
Publications (7)
Top publication keywords:
FolliculitisVancomycinPneumonia, Ventilator-AssociatedAnti-Bacterial AgentsCarbapenemsVancomycin-Resistant EnterococciCarbapenem-Resistant EnterobacteriaceaeIntensive Care UnitsVancomycin ResistanceTravel-Related IllnessFluoroquinolonesbeta-Lactam ResistanceAntimicrobial StewardshipFebrile NeutropeniaAeromonas
-
Levinson's Review of Medical Microbiology & Immunology, A Guide to Clinical Infectious Diseases
Levinson's Review of Medical Microbiology & Immunology, A Guide to Clinical Infectious Diseases 2024 Peter Chin-Hong, Elizabeth A. Joyce, Manjiree Karandikar, Mehrdad Matloubian, Luis Alberto Rubio, Brian S. Schwartz, Warren Levinson -
Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
Journal of the Pediatric Infectious Diseases Society 2020 Karandikar MV, Milliren CE, Zaboulian R, Peiris P, Sharma T, Place AE, Sandora TJ -
Variability in antimicrobial use in pediatric ventilator-associated events.
Infection control and hospital epidemiology 2018 Karandikar MV, Coffin SE, Priebe GP, Sandora TJ, Logan LK, Larsen GY, Toltzis P, Gray JE, Klompas M, Sammons JS, Harper MB, Horan K, Lakoma M, Cocoros NM, Lee GM -
Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.
Open forum infectious diseases 2018 Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH -
Safety and Tolerability of Moxifloxacin in Children.
Journal of the Pediatric Infectious Diseases Society 2018 Dixit A, Karandikar MV, Jones S, Nakamura MM -
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Antimicrobial agents and chemotherapy 2017 Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH -
Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature.
Journal of the Pediatric Infectious Diseases Society 2017 Olszewski AE, Karandikar MV, Surana NK